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Abstract
Subversion of genome integrity fuels cellular adaptation and is
a prerequisite for organismal evolution, yet genomic lesions
are also the harmful driving force of cancer and other age-
related human diseases. Genome integrity maintenance is
inherently linked to genome organization and nuclear archi-
tecture, which are substantially remodeled during the cell
cycle. Here we discuss recent findings on how actively dividing
cells cope with endogenous genomic lesions that occur
frequently at repetitive, heterochromatic, and late replicating
regions as byproducts of genome duplication. We discuss how
such lesions, rather than being resolved immediately when
they occur, are dealt with in subsequent cell cycle phases, and
even after mitotic cell division, and how this in turn affects
genome organization, stability, and function.
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Introduction
Among the main tasks of the cell nucleus are the func-
tional organization and stabilization of the genome. This
involves the spatial organization of DNA into nucleo-
somes, nucleosome clusters, chromatin loops, topologi-
cally associating domains (TADs), larger chromosome
compartments, and chromosome territories [1,2]. But it
also involves the constant remodeling of genome archi-
tecture to facilitate genome functions such as gene
expression, DNA replication, cell division, and DNA
repair. In this sense, the term genome architecture is
misleading, as the genome is far from being static.
Indeed, when genome organization is analyzed at single
cell resolution, a continuous cell cycleedependent
reorganization of chromatin domains is revealed [3].
Genome duplication during S-phase of the cell cycle,
chromosome condensation during mitotic cell division,
and chromosome decondensation in early G1 all repre-
sent major, yet in their spatiotemporal regulation
incompletely understood, genome remodeling events.
Maintaining genome integrity throughout these pro-
cesses is critical for cell function, and failure to do so is
associated with accumulation of mutations, chromo-
somal aberrations, and cellular transformation leading to
disease.
Genome integrity maintenance is the primary function
of two interconnected cellular networks, the DNA
damage response (DDR) [4,5] and the replication stress
response (RSR) [6]. While the DDR takes care of
chromosome breaks and other types of DNA lesions
throughout the cell cycle, the RSR is primarily active in
S-phase to deal with stalled replication forks and
harmful replication intermediates. Although they are
typically considered distinct cellular responses and
often studied separately, emerging evidence suggests
that certain replication intermediates, such as reversed
replication forks, structurally resemble DNA lesions and
that the DDR and the RSR employ a shared set of
molecular players to maintain a stable genome [7].
Furthermore, both the DDR and the RSR trigger cell
cycle checkpoints to slow down or halt cell cycle pro-
gression, and tight connections exist between the
mechanisms involved in genome integrity maintenance
and cell cycle control [8,9]. On the other hand, cell cycle
checkpoints are not failsafe. Accumulating evidence
suggests that replication intermediates and genomic
lesions originating from endogenous replication stress
can escape checkpoint surveillance and are transmitted
to subsequent cell cycle phases and even to the next cell
generation [10,11]. In this review we highlight and
discuss regions in the genome that are particularly
vulnerable to endogenous replication stress and thus
inherently fragile, and provide an update on the
emerging mechanisms used by cells to deal with this
fragility in a manner that encompasses multiple suc-
cessive cell cycle phases. As the genome undergoes
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significant reorganization when cells cross the borders
between cell cycle phases, for example, when they
progress from S/G2 into mitosis and from mitosis into
G1, we will put these mechanisms into the context of
nuclear compartmentalization and discuss how this in
turn may impact genome stability. Although dealing
with DNA lesions across cell cycle boundaries is not
limited to cancer cells, it may be particularly important
as a source of cancer driving mutations, to shape cancer
genome evolution, and to link deregulated genome
integrity maintenance and genotoxic cancer therapies to
innate immunity. Understanding the underlying princi-
ples and to which extent cancer cells rely on them may
therefore offer new opportunities for therapeutic
interventions.
Endogenous replication stress and
inherently fragile regions in the genome
Replication stress arises when replication fork pro-
gression is impaired [6]. This can occur in response to
DNA lesions caused by exogenous DNA damaging
agents, including many chemotherapeutic drugs, but it
can also occur during normal S-phase progression in
the absence of exogenous stress. Frequent replication
fork slowing and transient pausing thus appear to be
natural byproducts of genome duplication [7]. Among
the sources for such endogenous replication stress are
conflicts between the replication and transcription
machineries, unusual DNA structures such as G-
quadruplexes, bulky DNA-protein complexes, and
difficult-to-replicate regions in the genome. The latter
include chromosomal fragile regions, so-called
common and rare fragile sites, as well as repetitive
sequences at telomeres, centromeres, and ribosomal
DNA (rDNA) (Figure 1). In addition to being inher-
ently difficult to replicate, these regions are also
replicated late in the cell cycle, and, as we will
discuss in more detail below, their late replication
timing significantly shortens the time window avail-
able in S-phase to complete their replication. This in
turn primes them for replication carried on beyond S-
phase, by mechanisms, which on one hand provide a
safety net for completion of genome duplication
but which on the other hand also pose a threat to
genome integrity and render these regions particularly
vulnerable.
Chromosomal fragile sites
Chromosomal fragile sites are hotspots for DNA
breakage and aberrations such as deletions, duplica-
tions, and translocations in response to replication
stress [12]. Based on their prevalence, fragile sites are
typically classified as either rare or common (Figure 1).
While rare fragile sites, such as the CGG triplet
expansion in the FMR1 gene underlying fragile X syn-
drome, are found only in a small percentage of the
Figure 1
Fragile genomic regions. Repetitive, heterochromatic, and late replicating regions in the genome are inherently fragile and frequently experience
replication stress–associated damage. Fragile genomic regions include telomeres at chromosome ends and subtelomeric repeats, centromeres and
pericentromeric repeats, rDNA repeats in the nucleolus, as well as common and rare fragile sites.
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population, common fragile sites (CFSs), such as
FRA16D and FRA3B with the associated tumor sup-
pressor genes WWOX and FHIT, respectively, are pre-
sent in the general population and frequently mutated
in cancer [13]. CFSs are typically late replicating,
origin-scarce regions. They are composed of AT-rich
sequences, which can form secondary structures that
stall replication and impair repair [14], and they are
associated with very long genes at TAD boundaries that
can take more than one cell cycle to be fully tran-
scribed, inevitably evoking transcription-replication
conflicts [15,16]. This combination of challenges im-
pedes faithful and complete CFSs replication during S-
phase, leading to under-replicated DNA and endan-
gered CFSs stability [17]. Of note, transcription and
replication timing are intertwined, and it was recently
demonstrated that experimentally enhanced transcrip-
tion, induced by a strong promoter, triggers a switch to
earlier replication timing and alleviates fragility [18].
While this reinforces the notion that late replication of
CFSs underlies their fragility, a distinct class of early
replicating fragile sites in highly expressed gene clus-
ters has also been identified [19,20]. Their fragility is
consistent with the recent finding that oncogene acti-
vation induces firing of normally suppressed replication
origins within highly expressed genes, causing
transcription-replication interference upon premature
S-phase entry [21]. Fragility thus not only occurs
when time gets short at the end of S-phase but also at
the transition from G1 to S-phase when high tran-
scriptional activity collides with the rapid firing of ori-
gins to initiate replication.
Telomeres
Telomeres and the adjacent subtelomeric repeats are
the regions that protect chromosome ends (Figure 1).
In human cells, telomeres are composed of terminal
TTAGGG repeat sequences, which can span several
kilobases in length and which are characterized by
constitutive heterochromatin. Despite their hetero-
chromatic nature, the long noncoding RNA TERRA is
transcribed from subtelomeric repeats and forms
telomere-associated R-loops that can interfere with
telomere replication and stability [22,23]. Secondary
structures such as G-quadruplexes formed at telomeric
G-rich repetitive sequences also challenge replication
fork progression [24,25]. Replication stress at telo-
meres is further enhanced due to unidirectional repli-
cation downstream of the most distal origin, which
means that irreversibly stalled replication forks cannot
be rescued by dormant origin firing. Finally, the
telomere-associated t-loop formed by the terminating
single-stranded G-rich overhang and the tightly bound
proteins of the protective shelterin complex challenge
replisome progression and make telomere replication
inherently difficult [26].
Telomere length maintenance, which is needed to
overcome the end replication problem and achieve
replicative immortality, depends on the reverse tran-
scriptase telomerase, or in around 10e15% of cancers
(including gliomas, sarcomas, and pancreatic neuro-
endocrine tumors), on alternative lengthening of
telomeres (ALT) [24,27]. Telomere elongation by
ALT relies on break-induced replication, a
recombination-driven process that is initiated in the
context of DNA replication but then continues as
break-induced telomere synthesis beyond S-phase
[28e33]. Break-induced replication additionally con-
tributes to telomere fragility, and cancer cells using
ALT for telomere maintenance show higher levels
of telomere-associated replication stress compared
to telomerase expressing non-ALT cancer cells
[22,24,34,35].
Centromeres
Centromeres are the assembly sites for the kineto-
chore, the protein complex that makes the connection
between chromosomes and the spindle fibers, so that
the chromatids can be pulled toward opposite poles
during cell division (Figure 1). In human cells, cen-
tromeres are composed of a series of AT-rich head-to-
tail tandem repeats named alpha satellites, which extend
for several megabases [36]. Furthermore, the sur-
rounding pericentromeric DNA is also organized in
short tandem repeats. The repetitive nature of
centromeric and pericentromeric sequences, the for-
mation of DNA secondary structures, the heterochro-
matin environment and their generally late replication
timing all contribute to centromere fragility [37]. Due
to their central role for chromosome segregation,
centromeric and pericentromeric replication stress,
chromosome breaks and recombination are associated
with chromosomal aberrations and translocations in
cancer.
rDNA
Ribosomal DNA contains several hundred copies of
repeated gene sequences (Figure 1). The ribosomal
rRNAs, required for ribosome biosynthesis, are tran-
scribed from these rDNA repeats, making them the
most heavily transcribed regions in the genome. The
human rDNA repeats encompass several genomic loci,
with the 5 S rRNA gene repeats encoded by chromo-
some 1, and the 18 S, 5.8 S, and 28 S rRNA gene repeats
distributed over chromosomes 13e15 and 21e22 [38].
These head-to-tail repeat clusters on multiple chro-
mosomes come together in the nucleolus, a membrane-
less nuclear compartment. Due to an excess number of
rDNA repeats, not all repeats are transcribed into rRNA.
Silent rDNA repeats form tightly packed heterochro-
matin at the nucleolar periphery and, unlike actively
transcribed repeats within the nucleolus, are replicated
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late in S-phase. Rearrangements of rDNA repeats,
rDNA repeat expansions and contractions, and rDNA-
associated structural chromosomal aberrations are
frequently found in cancer. The instability of rDNA in
disease is likely driven by transcription-replication
conflicts due to R-loops at transcribed rDNA repeats,
and by replication impediments coming from silent,
heterochromatic rDNA repeats and from their late
replication timing.
Dealing with incompletely replicated DNA
beyond S-phase
As mentioned above, inherently fragile regions may not
only be susceptible to replication stress and DNA
damage because of their difficult-to-replicate sequence
but also because of their late replication timing. In
particular in cancer cells, where cell cycle checkpoint
control is loosened and premature cell cycle transitions
occur, late replicating regions may continue replication
Figure 2
Dealing with DNA lesions across cell cycle boundaries. While DNA replication is normally confined to the S-phase of the cell cycle, in response to
endogenous and exogenous replication stress, e.g. upon oncogene activation or loss of tumor suppressor genes, replication and recombination in-
termediates are transmitted to later stages of the cell cycle. Late replicating regions, in which replication problems occur late in S-phase, are predestined
for continuing replication in S/G2, and at under-replicated DNA replication continues even in mitosis. Mitotic DNA synthesis (MiDAS) is a conservative
form of break-induced replication that works at common fragile sites and telomeres. Upon exit from mitosis, unresolved replication intermediates and
chromosome breaks can give rise to micronuclei and free cytoplasmic DNA, such as extrachromosomal telomeric repeat DNA and C-circles, which in turn
can activate the cGAS-STING pathway and trigger a type I interferon response. In the context of cancer treatment, chemo- and radiation therapy
(including genotoxic cell cycle and DNA repair drugs such as ATR, WEE1, and PARP inhibitors) may thus synergize with immune response activating
checkpoint inhibitors to maximize cancer cell death. In the newly forming main nucleus, 53BP1 condensates shield inherited DNA damage and are
associated with clustering of difficult-to-repair lesions and a p53-p21-response. This extends G1 duration in response to replication stress during the
previous cell cycle and determines whether and when cells commit to the next round of replication. In absence of such failsafe mechanisms (e.g. upon
p53 or p21 loss), transgenerational lesion repair likely leads to a progressive accumulation of mutations and fuels cancer evolution.
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in G2 and even mitosis (Figure 2). Indeed, G2 could be
viewed as an extended S-phase [39], as a time in the cell
cycle when late replicating and under-replicated DNA is
taken care of. Replication stress, in particular at origin
scarce regions where fork stalling cannot be resolved by
dormant origin firing, exacerbates the amount of
incompletely replicated DNA. Likewise, shortening the
S/G2 phase by overriding intrinsic checkpoint control
and enforcing premature activation of mitotic processes,
e.g. through inhibition of the ATR, CHK1, and WEE1
kinases [40e45], increases the fraction of the genome
that has not been replicated fully. How do cells deal with
such under-replicated DNA? Surprisingly, DNA repli-
cation does not seem to stop upon mitotic entry, as
accumulating evidence has shown [46e52]. Mitotic
DNA synthesis (MiDAS) occurs at CFSs and fragile
telomeres and uses a form of break-induced replication.
This conservative form of DNA synthesis depends on
the replicative polymerase d and its subunit POLD3, on
the scaffolding factor SLX4, the MUS81-EME1 endo-
nuclease, and on the RAD52 recombinase [53e58]. The
switch from semi-conservative replication in S/G2 to
MiDAS also seems to require prior replisome disas-
sembly, which is mediated by the TRAIP ubiquitin
ligase and CDC48/p97-dependent extraction of the
replicative helicase from chromatin [59e62]. While the
mechanism of MiDAS at CFSs and telomeres and the
main players involved have started to emerge, to which
extent MiDAS occurs at centromeres, rDNA repeats,
and other fragile regions, and how different subpathways
of MiDAS may deal with different fragile loci are
currently not very well understood.
As genome duplication and cell division should be
temporally separated in order to ensure that the com-
plete genetic information is transmitted to the
offspring, MiDAS may be the last resort to complete
replication before chromosome segregation. Challenging
this paradigm, it was recently shown in budding yeast
that DNA synthesis is inhibited in metaphase due to
high CDK activity, and allowed to resume during
anaphase, late in mitosis when chromosomes separate
[63]. As mammalian MiDAS seems restricted to the
time window from prophase to metaphase, whether
post-metaphase DNA synthesis exists in human cells is
currently not known.
What happens when MiDAS fails, or time is simply too
short during mitosis to complete replication of under-
replicated DNA coming from S/G2? Unresolved repli-
cation intermediates can lead to mitotic chromatin
bridges, lagging chromosomes, nucleosome-free ultra-
fine anaphase bridges, and chromosome breaks [64e66].
These aberrations can give rise to 53BP1 nuclear bodies
in G1 cells, which shield inherited genomic lesions from
nucleolytic degradation and unscheduled repair re-
actions, and they can lead to broken DNA escaping from
the newly forming nucleus to generate micronuclei and
extrachromosomal DNA (Figure 2). Recent work has
started to shed light on the consequences of such
inherited genomic lesions, linking genome integrity
maintenance to nuclear organization by liquid conden-
sates and to cGAS-STING-mediated activation of
innate immunity.
Consequences of replication
stress–associated heritable DNA lesions
The time from nuclear envelope breakdown in prophase
to its reformation in telophase poses a particular threat
to genome integrity maintenance not only because of
the massive chromatin rearrangements that happen
during mitosis but also because the physical barrier that
normally prevents leakage of DNA into the cytoplasm is
gone. Although sophisticated mechanisms are in place to
keep mitotic chromosomes spatially constrained and to
separate nuclear from cytoplasmic components during
nuclear reassembly [67,68], broken pieces of chro-
mosomes can escape from the newly forming nucleus to
constitute micronuclei and cytoplasmic extrachromo-
somal DNA (Figure 2). Micronuclei have a fragile en-
velope that easily breaks down during interphase and
they show asynchronous replication, which on one hand
can lead to chromosome aberrations such as the complex
rearrangements seen in chromothripsis, and on the other
hand trigger, through cytoplasmic self-DNA sensing by
the cGAS-STING pathway, an innate immune response
[69,70,71]. Telomere fragility and dysfunction during
replicative crisis as well as extrachromosomal telomeric
repeat DNA have also been associated with chromo-
thripsis and cGAS-STING activation [72,73,74].
Nuclear escape of DNA late in mitosis as a consequence
of replication stress and incomplete MiDAS at fragile
genomic regions could therefore be a general mecha-
nism that links deregulated or impaired genome integ-
rity maintenance to genomic rearrangements and innate
immune signaling (Figure 2).
The cGAS-STING pathway is also activated in cells that
lost the tumor suppressors and homology-directed repair
factors BRCA1 or BRCA2 [75e79]. Importantly,
chemotherapeutic drugs that exacerbate replication
stress and DNA damage, such as PARP and ATR in-
hibitors, result in more problems late in the cell cycle
and during mitosis [41,80], and further stimulate the
cGAS-STING-mediated type I interferon response,
suggesting that such compounds can be exploited in
certain contexts to boost cancer immunotherapies
[81,82].
While mitotic exit bears the risk of losing damaged DNA
from the newly forming nucleus, re-establishing the
nuclear compartment also provides new opportunities to
deal with inherited DNA lesions on correctly segregated
chromosomes. The multivalent chromatin reader 53BP1
simultaneously senses replication status and presence of
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DNA damage and through its oligomerization domain
forms large compartments around genomic lesions in G1
cells (Figure 2). These protein condensates, which
promote repair and stabilize the chromatin topology in
the vicinity of DNA lesions [83], show many features
of liquideliquid phase separation (LLPS), including
concentration-dependent self-assembly and condensate
fusions [84,85]. They are precluded from forming
during mitosis, when the 53BP1 concentration is diluted
after nuclear envelope breakdown and when high kinase
activities, including CDK-dependent phosphorylations,
prevent LLPS and 53BP1 assembly [86,87]. In G1,
however, 53BP1 avidly assembles at inherited lesions
and, via p53 and its downstream target p21, modulates
G1 length and S-phase commitment [88e90]. Difficult-
to-repair lesions inside such condensates are particularly
prone to undergo clustering by compartment fusions
[84,91,92], resulting in repair centers that facilitate
repair but also bear the risk of promoting chromosomal
translocations. The role of 53BP1 extends beyond G1, as
it also impacts replication fork stability, replication
timing of inherited lesions, and coordinates the hand-
over to RAD52-mediated recombination later in the cell
cycle [93,94].
While 53BP1 condensates are primarily associated with
under-replicated DNA at CFSs, LLPS-mediated clus-
tering has recently been described for inherently fragile
telomeres in ALT-positive cancer cells [95,96]. ALT
telomeres, mediated by the SUMO pathway, assemble
into ALT-associated PML bodies (APBs), liquid-like
condensates in which inter- and intrachromosomal
break-induced replication occurs. As PML bodies are
also recruited to persistent ionizing radiation-induced
DNA lesions [97], compartmentalization into nuclear
condensates may emerge as a common theme for a
broader range of inherently fragile as well as difficult-to-
repair genomic regions.
Conclusions
As opposed to the classic cell cycle arrest, repair, and
restart model, work from recent years has started to
support the notion that certain genomic lesions take
more than one cell cycle phase and sometimes even
more than one cell cycle to be repaired. Particularly
replication stress-associated lesions and physiological
replication intermediates, such as stretches of under-
replicated DNA at late replicating regions in the
genome, have a comparatively short time-window for
repair in S-phase, and they depend on replication and
repair events in late S/G2 and mitosis. This makes them
especially fragile with consequences for genome stabil-
ity and for the detection of DNA damage by the immune
system.
Mutational cascades amplifying chromothripsis over
successive cell cycles, and segregation of unrepaired
genomic lesions over multiple cell generations drives
evolution, subclonal heterogeneity, and adaptation of
cancer genomes [98,99]. Furthermore, nonrandom
segregation of DNA lesions in response to replication
stress was recently shown to cause biased inheritance of
newly replicated DNA by daughter cells [100]. A
better understanding of the underlying mechanisms and
of the dynamic evolution of replication stress pheno-
types may not only yield information on the origin and
evolution of cancer but also hold promises for more
targeted treatments. ATR inhibitors, for instance,
enhance asymmetric distribution of replication stress-
associated DNA damage [100], and potentiate
cGAS-STING-mediated interferon signaling [81]. In
targeted cancer therapy, these two effects might
synergize for desired outcomes.
While CFSs were the first fragile regions to be linked to
53BP1 nuclear bodies and MiDAS, telomeric MiDAS
has recently received more attention. However, it is not
entirely clear yet how ALT-negative and ALT-positive
cancer cells differ in terms of MiDAS and replication
stress-associated telomere fragility. The fragility of
other genomic regions, including centromeres, peri-
centromeric repeats, and rDNA arrays, is even less well
understood. New technologies that can map fragile
regions and their replication genome-wide in specific
cell cycle phases have recently been developed
[101,102,103], and they will likely shed new light
on the mechanism of MiDAS-dependent recombina-
tion repair and also identify additional fragile regions.
Applied to different cell types with different sets of
activated oncogenes and inactivated tumor suppressors,
a more comprehensive and condition-specific view of
the fragile genome will be obtained. Complemented by
time-resolved single cell experiments to investigate the
fate of individual inherited DNA lesions for the next
cell generations, we will understand better how cells
deal with DNA damage when one cell cycle is not
enough.
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